Bliss GVS Pharma Ltd

Bliss GVS Pharma is engaged in manufacturing, marketing, trading and export of pharmaceutical products.

  • Market Cap: 1,003 Cr.
  • Current Price: 97.25
  • 52 weeks High / Low 166.00 / 73.75
  • Book Value: 68.08
  • Stock P/E: 9.40
  • Dividend Yield: 1.03 %
  • ROCE: 26.90 %
  • ROE: 21.19 %
  • Sales Growth (3Yrs): 17.99 %
  • Listed on BSE and NSE
  • Company Website
  • Face Value: 1.00
Edit ratios
Pros:
Company is virtually debt free.
Cons:
Company has high debtors of 187.22 days.
Promoter holding has decreased over last 3 years: -18.56%

Peer comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Indian - Formulations

Loading peers table ...

Quarterly Results Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019
258 225 226 196 167 205 228 220 244 212 210 148
181 161 179 148 130 165 187 177 212 163 185 115
Operating Profit 76 64 47 48 38 41 42 44 32 49 25 33
OPM % 30% 28% 21% 25% 22% 20% 18% 20% 13% 23% 12% 22%
Other Income -7 4 15 2 -29 14 25 -4 3 2 13 6
Interest 8 6 6 5 5 1 1 1 1 1 1 1
Depreciation 1 5 5 7 5 2 2 2 2 3 4 3
Profit before tax 60 56 52 39 -1 51 63 36 32 47 34 34
Tax % 29% 34% 23% 34% -853% 24% 34% 25% 41% 30% 9% 26%
Net Profit 33 21 34 18 -14 38 41 26 18 34 31 24
EPS in Rs 3.21 2.05 4.93 1.74 -1.39 3.72 4.02 2.50 1.76 3.28 3.00 2.30
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 TTM
219 267 397 345 407 547 798 815 898 814
160 196 285 273 304 391 596 621 738 674
Operating Profit 59 71 111 71 103 156 203 193 160 139
OPM % 27% 27% 28% 21% 25% 29% 25% 24% 18% 17%
Other Income 2 16 14 28 20 24 12 -4 35 23
Interest 2 4 10 18 16 19 20 23 4 4
Depreciation 5 4 6 11 11 13 20 21 9 11
Profit before tax 53 79 109 71 96 148 175 145 182 147
Tax % 23% 34% 46% 42% 36% 32% 36% 39% 30%
Net Profit 41 53 58 41 60 82 82 59 124 107
EPS in Rs 3.84 4.97 5.48 3.89 5.66 8.00 7.95 5.70 11.99 10.34
Dividend Payout % 15% 15% 12% 13% 12% 6% 8% 18% 8%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:%
5 Years:21.12%
3 Years:17.99%
TTM:-0.96%
Compounded Profit Growth
10 Years:%
5 Years:25.04%
3 Years:14.82%
TTM:-4.22%
Stock Price CAGR
10 Years:9.67%
5 Years:-2.20%
3 Years:-16.95%
1 Year:-38.57%
Return on Equity
10 Years:%
5 Years:19.08%
3 Years:18.33%
Last Year:21.19%

Balance Sheet Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Sep 2019
10 10 10 10 10 10 10 10 10 10
Reserves 156 200 248 277 327 402 476 526 636 692
Borrowings 8 45 148 173 160 132 225 118 102 98
39 54 165 123 166 218 311 206 157 177
Total Liabilities 213 310 571 583 662 762 1,023 860 905 978
20 40 168 213 234 225 305 143 146 168
CWIP 8 7 1 4 0 9 4 0 47 76
Investments 0 1 0 0 0 0 0 0 0 0
186 262 402 365 428 527 714 717 712 733
Total Assets 213 310 571 583 662 762 1,023 860 905 978

Cash Flows Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
36 6 41 38 113 289 18 40
-22 -124 -11 -29 -50 -249 48 -79
26 110 -8 -42 -40 -10 -76 17
Net Cash Flow 40 -8 22 -34 23 30 -10 -22

Ratios Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
ROCE % 39% 36% 20% 24% 32% 31% 29% 27%
Debtor Days 200 176 225 228 222 201 116 134 187
Inventory Turnover 12.97 9.00 5.25 5.36 7.14 8.16 7.22 8.98

Recent announcements

View all announcements

Annual reports

Credit ratings